Navigation Links
Texas Senator Tommy Williams Honored as 'Champion for Children' by the AMERIGROUP Foundation
Date:2/6/2008

VIRGINIA BEACH, Va., Feb. 6 /PRNewswire/ -- The AMERIGROUP Foundation today announced that Senator Tommy Williams of The Woodlands has been honored with its "Champion for Children" award.

The award is part of the AMERIGROUP Foundation's national program recognizing outstanding public advocacy efforts by government and community leaders in improving the health and well-being of the nation's children.

"Our goal is to work together with local leaders and citizens for the benefit of healthier communities, and that starts with children," said Aileen McCormick, CEO of AMERIGROUP Community Care in Texas. "Senator Williams and his efforts represent terrific examples of what we can all accomplish when we keep the end result in mind. His commitment to improving the Texas Medicaid system to encourage efficiency and preventive care offers a great example of how Texas can meet the critical goals of managing cost while also helping to improve the health of our children through innovative programs. We're thrilled to recognize Senator Williams for his work, and we're equally excited to witness achievements that will assist in making our kids and communities healthier."

To commemorate Senator Williams' commitment to children and their families a $2,500 Foundation check will be presented to the Interfaith of The Woodlands during a reception at the facility. Interfaith helps individuals in crisis through financial assistance for rent, mortgage, utilities, gasoline, prescription drug assistance, emergency shelter, food, family and individual counseling, job training, senior programs and child care.

Senator Williams said he is honored by the award and appreciative of the Foundation's support of The Woodlands.

"The AMERIGROUP Foundation's commitment and contributions focused on encouraging healthy families and communities have been tremendous," Williams said. "I appreciate the support of great organizations like Interfaith of The Woodlands that p
'/>"/>

SOURCE AMERIGROUP
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas
2. Texas Health Care Association Urges Texas Congressional Delegation to Fight Planned Federal Cuts to Medicaid, Medicare
3. Texas Health Care Association Launches New Educate 08 Effort to Help Focus Needed Attention on Long Term Care Issues, Medicaid Funding Crisis
4. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
5. Humanities Texas Announces Winners of The First Humanities Texas Award
6. Judge Rules Texas Mutual Insurance Co. Committed Litigation Fraud With Falsified Document, According to Doyle Raizner LLP
7. Doctors Group Sues Texas Medical Board for Misconduct; Cites Institutional Culture of Retaliation & Intimidation
8. Dallas-Fort Worth Business Group on Health Releases Report on the State of Diabetes in Texas
9. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice
10. S3 Matching Technologies Aids in Reducing Risk to Texas Medicaid System
11. Pelosi, Members of Texas Delegation to Rally for Childrens Health Care in San Antonio Tomorrow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)..., ANN ARBOR, Mich.---The University of Michigan ...f Health to develop the world,s leading resource o...ng compounds that will ultimately take computer-ai...will house the data needed to improve computer pro...ial new drugs, said Heather Carlson, associate pro...
(Date:10/10/2008)... SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCa...obal leader in the field of radiosurgery,today an...quarter fiscal,year 2009, ending September 27, 200... closes., A conference call to review the results...ill be hosted by Euan S. Thomson, Ph.D., president...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationall...treatment strategies for patients with breast,canc...reast Cancer,Strategies: From Biomarkers to Treatm...ness Month., It is challenging for practicing onc...s to stay up to date on the latest patient care,ad...
(Date:10/9/2008)... Let Them Hear Foundation hosts annual wine auc...amily venture, EAST PALO ALTO, Calif., Oct. 9 /PR...ls, California vintners, and local businesses and,...living in silence at the,fifth annual Crush the Si...Foundation at the Four Seasons Hotel, Silicon Vall...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Local Leaders Support Needy Individuals, Communities 2
...oject that allowed prisoners a safe way to sport t... ended in September 2006. Now, an AIDS activist ha...awa, outlining the benefits of tattoo parlors in p... of AIDS. It is estimated that nearly 17% of the ...
...ndful of nutrient-rich dried plums each day help k...s in postmenopausal women with osteoporosis or ost...y in the Florida State University College of Human...ssor Bahram H. Arjmandi is the principal investiga...
...s at the University of Pennsylvania School of Medi... of therapy for patients who suffer from high chol... issue of the New England Journal of Medicine (NEJ...ygous familial hypercholesterolemia (FH), a high-r...
...rich food and lack of exercise is lethal for the l...d as fatty liver disease,// it is characterized by...ebilitates the liver and could be a cause of scarr... liver. According to researchers, sedentary habit...
Other Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3
(Date:10/9/2008)...ire-FirstCall/ -- Diamyd Medical reports,that the ...England Journal,of Medicine, has published an arti...iamyd(R) diabetes vaccine for type 1 diabetes., (...4/297194 ), The article is now available on the ...l be in print on October 30. It presents the,resul...
(Date:10/8/2008)...ers Research That May Offer New Hope to,Heart Fail...ionally, over 3,000 people are,waiting for a heart... half,of those will receive a transplant. Now, pio...is paving the way for how to treat congestive hear... News Release, go to:, http://www.prnewswire.com/m...
(Date:10/8/2008)...y of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct...icals,Corporation (TSX: NVN) today presented posit...etary Toll-like Receptor 3 agonist, Poly IC-Poly,A...2008 in Lyon, France.,Study results demonstrated P...the Toll-like Receptor 3 (TLR3) pathway. Data show...
(Date:10/7/2008)...ire/ -- McLaren Health Care and its Great,Lakes Ca...eading medical,minds to share the latest work unde...al cancer treatments. The October 11th symposium, ...en,s Sukamal Saha, M.D., an,award-winning surgical...r,colorectal cancer has gained worldwide recogniti...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2AARP Calls for Action on Top Consumer Priorities 21189 1AARP Calls for Action on Top Consumer Priorities 21189 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 1Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 3OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 1OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 1AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 3
...ire-FirstCall/ -- IDM,Pharma, Inc. today announced... clinical trial and data from the Phase II EP-2101...al trial will be,presented at the 2007 American So...ing in Chicago on June 1-5 2007. , , UVIDEM pre...ogical responses in patients with malignant, ...
...rstCall/ -- Lev,Pharmaceuticals, Inc. ("Lev" or th... patient treatment in the prophylactic portion of,...tor (C1-INH) for,hereditary angioedema (HAE). The ...aluated the efficacy and safety of C1-INH,replacem...rophylactic treatment to prevent HAE attacks. , Le...
Other Medicine Technology:IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4
Duckbill. 3.5 mm tip. Light curve.
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle.
4 mm x 9 mm tip.
2 mm curved tip. Round handle. Designated most popular model or size.
Medicine Products: